Month: April 2017

In the Pursuit of Precision Medicine and Value-Based Care: Are They Dual, Yet Synergistic Goals?

In the Pursuit of Precision Medicine and Value-Based Care: Are They Dual, Yet Synergistic Goals? April 26, 2017 by Heather Landi Within the healthcare industry, precision medicine often is approached as a research endeavor, while value-based care transformation is framed as a business or operational initiative. However, one bioinformatics thought-leader asserts that precision medicine and Read More …

FROM FDA: Table of Pharmacogenomic Biomarkers in Drug Labeling

Table of Pharmacogenomic Biomarkers in Drug Labeling Pharmacogenomics can play an important role in identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose. Drug labeling may contain information on genomic biomarkers and can describe: Drug exposure and clinical response variability Risk for adverse events Genotype-specific dosing Mechanisms of drug action Polymorphic Read More …